Amcor Bemis Acquisition: What It Actually Means for Packaging Buyers

If you're a packaging buyer, the Amcor Bemis acquisition probably sounded like a one-stop shop dream. In practice, it's more complicated. I manage procurement for a mid-sized food manufacturer—roughly $2.5M annually across 12 packaging vendors. When the merger closed in 2019, I was hopeful. Three years later, I've learned that bigger doesn't always mean better for your specific needs.

Here's what you actually need to know, not the press release version.

The Short Version: What Changed and What Didn't

The big win: R&D and material science. Amcor's global scale plus Bemis's healthcare and barrier film expertise created a legit powerhouse in innovation. We've seen tangible improvements in shelf-life testing data for our flexible packaging since the merger.

The catch: Sales and service got more complex. Pre-merger, I had a dedicated Bemis rep who knew our account inside out. Post-merger, that relationship got folded into Amcor's regional structure. Our rep changed three times in the first 18 months. (Which, honestly, was frustrating.)

The middle ground: Product breadth is real, but integration is uneven. I can now theoretically source both our primary flexible packaging and secondary healthcare-grade materials from one supplier. Theoretically. In practice, different divisions still operate somewhat independently—ordering across product lines isn't as seamless as the marketing suggests.

Why "One-Stop Shop" Deserves Skepticism

In my first year as a buyer, I made the classic rookie mistake: I assumed "standard" meant the same thing to every vendor. Learned that lesson the hard way with a $600 redo on spec mismatch.

The same principle applies here. A supplier who claims to do everything well often does many things adequately and a few things excellently. The Amcor-Bemis merger created breadth, but depth varies by division and geography.

What I've found: If your core need aligns with Bemis's historical strength—healthcare packaging, high-barrier films, medical device packaging—the merger works well. If you're looking for a generic flexible packaging supplier, you might be paying for capabilities you don't need.

Here's what I wish someone had told me: Ask your potential rep, "What's your division's specialization?" If they can't answer clearly, that's a red flag. The best suppliers know their limits. A rep who said, "This isn't our strength—here's who does it better," earned my trust for everything else.

Real Numbers: What We've Seen

I don't have hard data on industry-wide pricing changes post-merger, but based on our experience and conversations with three peer companies (similar size, different verticals), here's the pattern:

• Pricing: Up roughly 3-7% across standard film grades since 2019. Hard to attribute solely to the merger—raw material costs rose ~15% in the same period.
• Lead times: Improved for high-volume, standardized products (they consolidated production). Worsened for custom/short-run orders (more bureaucracy).
• Quality consistency: Largely unchanged. Their barrier technology is genuinely best-in-class. Defect rates on our medical device pouches run ~0.3%, which is excellent.

Compare this to industry benchmarks from FDA filings: average defect rates for medical packaging are 0.5-2%. So Bemis's performance remains strong. But it's not magic—it's process discipline.

When the Merger Actually Works in Your Favor

Three scenarios where we've seen real benefit:

1. Cross-divisional projects. If you're launching a product that needs both food-grade flexible packaging AND a healthcare-compatible secondary package, having both under one roof reduces coordination headaches.
2. Global supply chain. Our European expansion was smoother because we could leverage Amcor's manufacturing footprint. The Bemis technology transferred, but the production local to our new facility.
3. Sustainability reporting. Amcor's sustainability infrastructure is more mature. Their recyclability data and documentation saved our regulatory team about 40 hours annually.

Where It Falls Short

Small-to-medium buyers beware. Our annual spend of $2.5M puts us in the "medium" category. I've heard from smaller companies (under $500K annual) that they struggle to get attention post-merger. The sales team prioritizes large accounts. That's not unique to Amcor, but it's more pronounced with a combined entity this size.

Also: Innovation isn't equally distributed. The barrier film R&D is impressive. But if you need commodity shrink film or basic pouches, you might be better off with a specialist who competes on price rather than a giant competing on scope.

One more thing—and this is honest: If your business relies on nimble, responsive supplier relationships, a post-merger giant might feel bureaucratic. I've had to escalate three times in the last year for what used to be a single-email fix. That's the trade-off.

The Bottom Line (With Honest Caveats)

The Amcor Bemis merger created a packaging powerhouse with legitimate strengths in healthcare and barrier technology. For the right buyer—complex needs, global operations, requiring high technical expertise—it's a strong option.

But if your situation doesn't match that profile? Don't default to the biggest name. A specialist who admits "We're great at X, not great at Y" is often more useful than a giant who promises everything.

My advice: Start with your specific packaging requirement, not the supplier's brand. The merger didn't change that fundamental truth.

As of early 2025, Amcor Bemis remains a top-tier option for healthcare and advanced barrier films. For basic flexible packaging? Shop around. You might be paying for a halo effect that doesn't benefit your bottom line.